Dextranomer/hyaluronic acid injections for patients with vesicoureteral reflux
Canadian Urological Association Journal2025Vol. 19(10), pp. 349–355
Bryce Weber, Faisal Mandourah, Amr Hodhod, Hadeel Eid, Carolina Fermin-Risso, Mutaz Farhad, Steven Lu, Jarrah Aburezeq, Abdullah Al-Soufiani, Anthony Cook, Mohamed El-Gharbaway
Abstract
In our cohort, 26.5% of renal units underwent repeated Dx/HA injections. Forty-four percent of units with repeated injections had grade 4-5 VUR. Patients with VUR who were injected or presented with fUTI before the age of one year old were at higher risk of repeated injections than those who were injected or presented later.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)